AMYRIS

Company Snapshot

Founded: 2003

Entity Type: Private

Region: U.S.

Headquarter: California, U.S.

Key Geographics: North America, South America, Europe, Asia-Pacific

AMYRIS In Reports

Synthetic Biology: Global Markets

BCC Research Market Analyst says global market for synthetic biology products was valued at $15.4 billion in 2023. The market is projected to grow from $19.3 billion in 2024 to $61.6 billion by the end of 2029.

Microbial Products: Technologies, Applications and Global Markets

BCC Research Market Report says microbes and microbial products is estimated to increase from $242.0 billion in 2022 to reach $346.3 billion by 2027, at a CAGR of 7.4%.

Biorefinery Products: Global Markets

BCC Research Market Analysis Report says Biorefinery Industry is estimated to increase from $624.7 bln in 2022 to $920.0 bln by 2027, at a CAGR of 8.0%.

View All Reports

AMYRIS In News

Amyris Buys Ingredion’s Stake in the Real Sweet Joint Venture - MSN

MSN - Jul 02, 2025

Amyris Assumes Full Control of Brazilian Plant, Ingredion Gains Sole Access to Fermentation Tech - vegconomist - the vegan business magazine

vegconomist - the vegan business magazine - May 30, 2025

Lawsuit claims Amyris' downfall linked to CEO's risky deals and silencing of dissenting voices - The Business Journals

The Business Journals - Apr 02, 2025

Amyris Awarded Agreement from BioMaP-Consortium to Develop Critical Medicines to Support Resilient Domestic Supply Goals - PR Newswire

PR Newswire - Oct 03, 2024

Read All News

Company's Business Segments

Products : The company generates revenue from products such as Sclareol, Hemisqualane, Santalols, Manool, Bisabolol, Biofene, Artemisinin, Biosilica, Others